Robocath and MicroPort finalize joint venture for robotic platform in China

Robocath and MicroPort, through its subsidiary MedBot, finalized a joint venture to commercialize Robocath's R-One robotic-assisted platform in China. Robocath holds 49% and MedBot 51% of the joint venture.

“Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces creation of the joint venture with MicroPort Scientific Corporation ‘MicroPort’, through ‘MedBot’, its MicroPort MedBot (Shanghai) Co. Ltd subsidiary.”robocath.com

• 1 source
• robocath.comRobocath finalizes creation of the joint venture with MicroPort through its medical robotic subsidiary MedBot – RobocathNov 2, 2020

Summarized from public sources; check the original articles before acting on it.